Integer Holdings Co. (NYSE:ITGR) Position Boosted by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. grew its position in shares of Integer Holdings Co. (NYSE:ITGR) by 0.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 259,830 shares of the medical equipment provider’s stock after purchasing an additional 1,941 shares during the quarter. Envestnet Asset Management Inc. owned 0.78% of Integer worth $30,086,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC boosted its stake in Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 142 shares in the last quarter. Envestnet Portfolio Solutions Inc. boosted its position in shares of Integer by 3.6% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider’s stock valued at $689,000 after purchasing an additional 205 shares in the last quarter. Arizona State Retirement System grew its stake in shares of Integer by 2.4% in the 2nd quarter. Arizona State Retirement System now owns 9,378 shares of the medical equipment provider’s stock worth $1,086,000 after purchasing an additional 219 shares during the last quarter. Guidance Capital Inc. raised its holdings in shares of Integer by 7.4% in the 2nd quarter. Guidance Capital Inc. now owns 4,527 shares of the medical equipment provider’s stock worth $538,000 after purchasing an additional 310 shares in the last quarter. Finally, QRG Capital Management Inc. lifted its stake in Integer by 1.1% during the first quarter. QRG Capital Management Inc. now owns 31,368 shares of the medical equipment provider’s stock valued at $3,660,000 after purchasing an additional 332 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have issued reports on ITGR shares. Benchmark reaffirmed a “buy” rating and issued a $130.00 price target on shares of Integer in a report on Friday, August 2nd. Oppenheimer started coverage on Integer in a report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and an average price target of $133.86.

Integer Stock Performance

Shares of Integer stock opened at $129.19 on Friday. Integer Holdings Co. has a 12 month low of $69.40 and a 12 month high of $131.87. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73. The stock has a market cap of $4.33 billion, a PE ratio of 44.70, a price-to-earnings-growth ratio of 1.81 and a beta of 1.09. The business has a fifty day simple moving average of $122.98 and a 200-day simple moving average of $118.60.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm had revenue of $436.20 million during the quarter, compared to analyst estimates of $437.00 million. During the same period last year, the company posted $1.14 EPS. The business’s quarterly revenue was up 9.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Integer Holdings Co. will post 5.31 EPS for the current fiscal year.

Insiders Place Their Bets

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the sale, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.